JAMES VERSALOVIC to Anti-Bacterial Agents
This is a "connection" page, showing publications JAMES VERSALOVIC has written about Anti-Bacterial Agents.
Connection Strength
0.684
-
Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology. 2009 May; 136(6):2015-31.
Score: 0.141
-
An unusual cause of sepsis and meningitis in a neonate. Semin Pediatr Infect Dis. 2006 Oct; 17(4):187, 225-7.
Score: 0.118
-
Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis. Infect Immun. 2017 10; 85(10).
Score: 0.063
-
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother. 1997 Aug; 40(2):283-6.
Score: 0.062
-
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother. 1996 Feb; 40(2):477-80.
Score: 0.056
-
The human microbiome and its potential importance to pediatrics. Pediatrics. 2012 May; 129(5):950-60.
Score: 0.043
-
Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol. 2009 Jun; 47(6):1628-30.
Score: 0.035
-
Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg. 2005 Aug; 242(2):193-200.
Score: 0.027
-
Reuterin disrupts Clostridioides difficile metabolism and pathogenicity through reactive oxygen species generation. Gut Microbes. 2020 11 09; 12(1):1788898.
Score: 0.020
-
Frameshift mutations in rdxA and metronidazole resistance in North American Helicobacter pylori isolates. J Antimicrob Chemother. 2000 Nov; 46(5):793-6.
Score: 0.020
-
Development of the cutaneous microbiome in the preterm infant: A prospective longitudinal study. PLoS One. 2017; 12(4):e0176669.
Score: 0.015
-
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother. 1997 Mar; 41(3):712-4.
Score: 0.015
-
Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study. J Clin Gastroenterol. 2014 May-Jun; 48(5):407-13.
Score: 0.012
-
Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe. 2012 Nov 15; 12(5):611-22.
Score: 0.011
-
Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007. Infect Control Hosp Epidemiol. 2010 Feb; 31(2):183-90.
Score: 0.009
-
National Institutes of Health Gastrointestinal Microbiota and Advances in Prebiotic and Probiotic Research conference summary. Gastroenterology. 2009 May; 136(5):1473-5.
Score: 0.009
-
Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006 Apr; 25(4):349-53.
Score: 0.007
-
Burkholderia gladioli osteomyelitis in association with chronic granulomatous disease: case report and review. Pediatr Infect Dis J. 2005 Sep; 24(9):837-9.
Score: 0.007
-
Molecular resistance testing of Helicobacter pylori in gastric biopsies. Arch Pathol Lab Med. 2001 Apr; 125(4):493-7.
Score: 0.005
-
Molecular typing of Helicobacter pylori isolates from a multicenter U.S. clinical trial by ureC restriction fragment length polymorphism. J Clin Microbiol. 1997 Feb; 35(2):471-3.
Score: 0.004
-
Vertical transmission of Citrobacter diversus documented by DNA fingerprinting. Infect Control Hosp Epidemiol. 1995 Oct; 16(10):564-9.
Score: 0.003